Middle East and Africa Cybersecurity Market worth $36.2 billion by 2028 – Exclusive Report by MarketsandMarkets™


The Middle East and Africa Cybersecurity Market size is estimated at USD 22.2 billion in 2023 and is projected to reach USD 36.2 billion by 2028, at a CAGR of 10.2% from 2023 to 2028, according to a new report by MarketsandMarkets™. Factors such as increasing number of cyber threats and attacks; and digital transformation initiatives are positively driving the growth of Middle East and Africa cybersecurity market. Furthermore, growth of eCommerce and digital payments along with stringent regulations and compliance requirements are also contributing to drive the market growth.

Browse in-depth TOC on “Middle East and Africa Cybersecurity Market”
436 – Tables
44 – Figures
385 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=190673806

By Component, Software segment is expected to account for the largest share in 2023

Software solutions offered in the Middle East and Africa Market are comprehensive cybersecurity solutions designed to help organizations meet all legal, IT, operational, and risk-related requirements. Some companies offer dedicated cybersecurity solutions, such as Identity and Access Management (IAM), antivirus/antimalware, firewall, log management, SIEM, encryption and tokenization, compliance and policy management, and patch management. These solutions are specifically developed to cater to the specific needs of end users. These solutions are designed to help organizations gain real-time threat-related insights and safeguard the security posture against future instances of these attacks.

By Software, Log Management and SIEM to account for the largest share in 2023

Software tools such as Security Information and Event Management (SIEM) and log management are utilized by IT organizations to keep track of their security status by analyzing log files, detecting and responding to any indications of compromise, and conducting investigations into potential network attacks. Log management involves the continuous collection, storage, processing, synthesis, and analysis of data from various programs and applications to optimize system performance, identify technical issues, manage resources effectively, enhance security, and ensure compliance. A log file is a record created by a computer that documents system activity, including messages, error reports, file requests, and transfers, which are typically predetermined by system administrators.

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=190673806

By Region, Middle East is expected to account for the largest share in 2023

The Middle East is home to many countries with rapidly growing economies and advanced technological infrastructures, making it an attractive target for cybercriminals and state-sponsored hackers. The region faces a variety of cybersecurity threats, including hacking attempts, data breaches, malware attacks, and ransomware. These threats can come from both external and internal sources and can target a range of industries and organizations, including government agencies, financial institutions, and businesses of all sizes. To address these threats, many countries in the Middle East have developed cybersecurity strategies and initiatives, such as establishing national cybersecurity centers, developing legislation to combat cybercrime, and investing in cybersecurity education and training programs.

Major players operating in the Middle East and Africa Cybersecurity Market are IBM (US), Cisco (US), Palo Alto Networks (US), Check Point (Israel), Trend Micro (Japan), Fortinet (US), Norton LifeLock (US), Sophos (UK), Kaspersky (Russia) and Trellix (US) are some of the market players.

Browse Adjacent Markets: Information Security Market Research Reports & Consulting

Browse Other Reports:

Customer Engagement Solutions Market – Global Forecast to 2027

Product Engineering Services Market – Global Forecast to 2027

Video as a Service Market – Global Forecast to 2026

Asset Performance Management Market – Global Forecast to 2026


Middle East Blood Plasma Derivatives Market Size to Reach $3.0 Billion, by 2031 at 9.4% CAGR: Allied Market Research


Allied Market Research published a report, titled, Middle East Blood Plasma Derivatives Market by Type (Albumin, Factor VII, Factor IX Concentrate, Anti-Coagulation Factor, Rh Immunoglobulin, and Others), by Application (Immunodeficiency Diseases, Bleeding Disorders, Liver Conditions, and Others), by End User (Hospitals, Clinics, and Transfusion Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031.” According to the report, the global middle east blood plasma derivatives market generated $1.1 billion in 2021, and is estimated to reach $3.0 billion by 2031, witnessing a CAGR of 9.4% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscapes, and competitive scenarios.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/53998

Drivers, Restraints, and Opportunities-

Rise in the prevalence of life-threatening disorders such as immunodeficiency disorders and hemophilia, and rise in awareness among the health professional regarding medicinal use of blood plasma drive the growth of the global middle east blood plasma derivatives market. On the other hand, side effects associated with blood plasma derivative therapy and prohibitive cost of therapy restrain the growth to some extent. However, surge in promotional activities by manufacturers and rise in awareness about usefulness of blood donation and plasma donation among individuals are expected to create lucrative opportunities in the industry.

Covid-19 scenario-

  • The rise in the usage of plasma derivatives for treatment of COVID-19 is anticipated to have positive impact on the middle east blood plasma derivative market. Moreover, rise in the number of blood donation and plasma donation activity during COVID-19 is anticipated to drive the growth of market.
  • With the emergence of the COVID-19 pandemic, the demand for plasma derivatives such as albumin, immunoglobulin, and coagulation factors has increased significantly. In addition, the availability of safe and effective plasma derivatives for a variety of medical applications has made them highly sought after in the Middle East region.

The hospitals segment to maintain its dominance during the forecast period-

By end user, the hospitals segment held the largest share in 2021, garnering nearly three-fourths of the global middle east blood plasma derivatives market revenue, and is projected to maintain its dominance by 2031. The same segment would also showcase the fastest CAGR of 9.7% during the forecast period. This is driven by the considerable number of patient visits to the hospitals for blood donation, increase in prevalence immunodeficiency disorders, & bleeding disorders and rise in number of hospitalization.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/53998

The bleeding disorder segment to rule the roost-

By application, the bleeding disorder segment contributed to more than one-thirds of the global middle east blood plasma derivatives market share in 2021, and is projected to rule the roost by 2031. The same segment would also display the fastest CAGR of 9.9% throughout the forecast period. Increase in prevalence of bleeding disorder and surge in application of blood plasma derivatives for treatment of bleeding disorders in middle east fuel the segment growth.

Rest of Middle East garnered the major share in 2021-

By region, Rest of Middle East held the major share in 2021, garnering more than three-fifths of the global Middle East Blood Plasma Derivatives market revenue, and is expected to dominate by 2031. This is due to the prevalence of hemophilia, and life threating disorder. Saudi-Arabia, on the other hand, would showcase the fastest CAGR of 10.5% from 2022 to 2031.

Leading Market Players-

  • Bayer AG
  • Biotest AG
  • CSL Limited
  • Fusion Healthcare Pvt. Ltd.
  • Grifols, S.A.
  • Kedrion Biopharma, Inc.
  • LFB S.A.
  • Octapharma AG
  • Sanofi
  • Takeda Pharmaceutical Co., Ltd.

The report analyzes these key players in the global middle east blood plasma derivatives market. The report is helpful in determining the business performance, operating segments, developments, and product portfolios of every market player.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Internet of Things in Healthcare Market by Component (Devices, System & Software, and services), Application (Patient Monitoring, Clinical Operation & Workflow Optimization, Connected Imaging, Fitness & Wellness Measurement, and Drug Development) and End User (Healthcare Providers, Patients, Healthcare Payers, Research Laboratories, and Government Authority): Global Opportunity Analysis and Industry Forecast, 2020-2030

Digital Pathology Market by Type (Scanners, Software, and Storage & Communication Systems), Application (Teleconsultation, Disease Diagnosis, Drug Discovery, and Training & Education), and End User (Educational, Clinical, and Pharma & Biotech Companies): Global Opportunity Analysis and Industry Forecast, 2021-2030

Albumin Market by Type (Human Serum Albumin, Bovine Serum, and, Recombinant Albumin) and Application (Therapeutics, Drug Formulation & Vaccines, Component of Media, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Gene Therapy Market by Vector Type (Viral Vector, Non Viral Vector), by Therapy (In Vivo Therapy, Ex Vivo Therapy), by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), by Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030

Biopharmaceuticals Market By Type (Monoclonal Antibody, Interferon, Insulin, Growth & Coagulation Factor, Erythropoietin, Vaccine, Hormone, and, Others) and Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, and Others) – Global Opportunity Analysis And Industry Forecast, 2020-2030

Culture Media Market by Type (Lysogeny Broth, Chemically Defined Media, Classical Media, Serum-free Media, Specialty Media, Stem Cell Media, Custom Media Formulation, and Others), Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, Stem Cell Technologies, Drug Discovery, and Others), Research Type (Cytogenetics, Cell Therapy, and Others), and End User (Biotechnology & Pharmaceutical Industry, Academic Institute, Research Laboratory, and Others):Global Opportunity Analysis and Industry Forecast, 2021-2030

Digital PCR Market  by Technology (Droplet Digital Pcr, Chip Based Digital Pcr, Beaming Digital Pcr), by Product Type (Digital Pcr Systems, Consumables And Reagents, Software And Services), by Application (Research, Clinical Diagnostics, Forensic And Others), by End User (Pharmaceuticals And Biotechnology Industries, Clinical Diagnostic Laboratories, Universities And Other Organizations), : Global Opportunity Analysis and Industry Forecast, 2020-2030

Interventional Oncology Market by Product [Ablation Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Others), Particle Embolization (Radioembolic agents, Drug-Eluting Beads, and Others), Support Devices]: Global Opportunity Analysis and Industry Forecast, 2021-2031

Antibiotics Market by Class (Beta Lactam & Beta Lactamase, Quinolones, Macrolides, and Others), Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic and Narrow-spectrum Antibiotic), and Route of Administration (Oral, Intravenous, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Gloves Market by Type (Disposable Sterile Gloves, Disposable examination and protective gloves, and Consumer gloves), and Industry (Medical, Horeca (food), Cleaning, Beauty, Food and Drinks, Pharmaceutical, Chemical, Automotive, Electronics, Construction, and Others): Global Opportunity Analysis and Industry Forecast 2021-2030


CoverGo expands its presence in the Middle East with a strategic investment from Noria Capital


CoverGo, the leading global no-code insurance SaaS platform for P&C, health, and life, is expanding to the Middle East after a US$15 million Series A funding, with a Middle East insurance fund Noria Capital joining as one of the strategic investors.

CoverGo has been adopted by a growing number of P&C, health and life insurance companies and emerging insurtech companies across the globe to build and launch all types of insurance products within days, develop omni-channel distribution and digitize policy admin and claims. CoverGo’s clients include AXA, Bupa, MSIG (MS&AD), Dai-ichi Life, DBS Bank, Bank of China Group Insurance and many others.

CoverGo has recently set up its presence in the Dubai International Financial Centre (DIFC) and became part of DIFC FinTech Hive, the largest financial technology accelerator in the Middle EastAfrica and South Asia region.

CoverGo’s expansion in the Middle East is led by newly appointed Regional Director George Majdalani. George is a senior executive with over 17 years in digital insurance transformation and health insurance innovation.

“CoverGo’s next-generation no-code platform provides insurance companies with an unbeatable speed to market and cost savings while driving efficiencies across the whole value chain. CoverGo is uniquely positioned to become the insurance platform market leader, in particular for health insurance in the Middle East, and help companies accelerate their digital transformation without heavy IT development”, said Rakan Abunayyan, General Partner of Noria Capital. “We are excited to support CoverGo on its growth journey and expansion in the Middle East as well as the African market.”

Middle East insurance companies are realizing now more than ever that custom IT development is too slow and costly while rigid legacy systems can’t satisfy changing customer needs and product requirements. As a result, we have seen a fast-growing demand for CoverGo as a truly configurable no-code platform,” said Tomas Holub, Founder & CEO of CoverGo. “The strategic investment from Noria Capital will further accelerate CoverGo’s growth in the Middle East and provide relationships with key partners and insurance companies in the region.”

“CoverGo’s no-code API-driven insurance platform is a perfect fit for the Middle East insurance stakeholders who are looking to launch and efficiently manage new innovative products and enable seamless digital distribution without disrupting their existing systems,” said George Majdalani, Regional Director, MENA.